EMCrit FOAM Feed

EMCrit Wee – The Philosophy of APRV – TCAV with Nader Habashi

04.11.2020 - By Scott D. Weingart, MD FCCMPlay

Download our free app to listen on your phone

Download on the App StoreGet it on Google Play

This is part 2 of the APRV - TCAV series. In part 1, I gave a primer on APRV. In this 2nd episode, I speak with the creator of the TCAV method of APRV, Nader Habashi.

Nader Habashi, MD, FACP, FCCP

Department of Trauma Critical Care Medicine, R Adams Cowley Shock Trauma Center, University of Maryland School of Medicine, Baltimore, Maryland, USA

Dr. Nader Habashi is a Professor of Medicine at the University of Maryland School of Medicine and the Medical Director of the Multi-trauma Critical Care Unit at the R Adams Cowley Shock Trauma Center (STC) in Baltimore, Maryland, USA. He also serves as the Medical Director for the Respiratory Therapy Department of the STC. Additionally, Dr. Habashi is the Medical Director for the Organ Procurement Organizations in Maryland (The Living Legacy Foundation) and Los Angeles, California (One Legacy). He is board certified in the areas of Internal Medicine, Critical Care Medicine, Pulmonary Medicine and Neuro Critical Care Medicine.

Dr. Habashi’s major study interests include alveolar mechanics and mechanical ventilation, mechanical breath profile and clinical management of organ donors. Dr. Habashi collaborates with Syracuse University Medical Center in large and small animal models.

COI: Dr Habashi reports presenting at conferences sponsored by or in part by Dräger Medical between 2010 and 2015 for which he received remuneration for honoraria and travel. He is also a founder of Intensive Care On-line Network (ICON) and presented webinars hosted by ICON between 2010 and 2015 and continues to present such webinars and assist clinicians with questions, without any remuneration received. Dr Habashi also reports that he has been issued 2 patents for a ventilation method related to initiating, managing, and/or weaning airway pressure release ventilation and controlling a ventilator in accordance with this method. To date, the patents have not been licensed to any manufacturer and no monetary gain has resulted from the patents.

Resolution: No specific companies were mentioned in the podcast. All topics were discussed generically.

APRV-TCAV Recruitment of Alveoli

Stuff Mentioned

* Physiology in Medicine: Understanding dynamic alveolar physiology to minimize ventilator-induced lung injury

More episodes from EMCrit FOAM Feed